2023
DOI: 10.1161/jaha.123.031121
|View full text |Cite
|
Sign up to set email alerts
|

Phenotypic Switching of Vascular Smooth Muscle Cells in Atherosclerosis

Runji Chen,
David G. McVey,
Daifei Shen
et al.

Abstract: The medial layer of the arterial wall is composed mainly of vascular smooth muscle cells (VSMCs). Under physiological conditions, VSMCs assume a contractile phenotype, and their primary function is to regulate vascular tone. In contrast with terminally differentiated cells, VSMCs possess phenotypic plasticity, capable of transitioning into other cellular phenotypes in response to changes in the vascular environment. Recent research has shown that VSMC phenotypic switching participates in the pathogenesis of at… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(7 citation statements)
references
References 99 publications
(216 reference statements)
1
3
0
Order By: Relevance
“…An intrinsic alteration of smooth muscle cell contraction‐relaxation dynamics is also an early change observed in our study, along with fibrogenic differentiation of SMCs, with reduced MYH11 and desmin expression and increased COL1A1 expression already evident in asymptomatic DIV. Altogether, our data provide unequivocal identification of a phenotypic switch 26,27 . Furthermore, the knowledge that phenotypic switch of SMCs can occur in the context of oxidative stress 28 further strengthens our hypothesis.…”
Section: Discussionsupporting
confidence: 78%
“…An intrinsic alteration of smooth muscle cell contraction‐relaxation dynamics is also an early change observed in our study, along with fibrogenic differentiation of SMCs, with reduced MYH11 and desmin expression and increased COL1A1 expression already evident in asymptomatic DIV. Altogether, our data provide unequivocal identification of a phenotypic switch 26,27 . Furthermore, the knowledge that phenotypic switch of SMCs can occur in the context of oxidative stress 28 further strengthens our hypothesis.…”
Section: Discussionsupporting
confidence: 78%
“…Our data suggest that this may occur by promoting abnormal secretion of new matrix and preventing controlled degradation of abnormal matrix proteins. Interestingly, these conditions fit within the well-reported progression of fibrotic diseases, where an increase in matrix stiffness is accompanied by inflammation and a worse prognosis or clinical outcomes, such as in breast cancer (37), diabetes (38,39), and cardiovascular diseases (40,41). More importantly, this points to a potential target for cancer therapy (42), where the gradual fibrosis of the premalignant microenvironment that is known to promote malignant transformation may be therapeutically intercepted before the tumor-prone region becomes cancerous.…”
Section: Discussionsupporting
confidence: 74%
“…In addition to focusing on the side effect, we should also note that long-term inhibition of Skp2 may also have other beneficial effects when targeting non-cancer cells. For example, long-term inhibition of Skp2 may improve cardiovascular pathogenesis associated with abnormal proliferation of hepatic stellate cells and vascular smooth muscle cells, such as liver fibrosis (Medina Pizaño et al, 2023) and atherosclerosis (Chen et al, 2023b). Therefore, when using Skp2 inhibitors, the balance between the therapeutic effects and the side effects of Skp2 inhibitors may influence the final outcome of disease treatment.…”
Section: Discussionmentioning
confidence: 99%